(2)
|
Annex II is amended and corrected as follows:
(a)
|
in Chapter 4, model OV/CAP-X is corrected as follows:
(i)
|
points II.2.2 and II.2.3 are replaced by the following:
‘II.2.2.
|
have remained continuously:
(i)
|
in the zone referred to in point II.2.1 since birth or for a period of at least six months prior to the date of their dispatch to the Union, and
|
(ii)
|
in the establishment of origin since birth or for a period of at least 40 days prior to the date of their dispatch to the Union, into which during this period no ovine and caprine animals and no animals of other species listed for the same diseases as ovine and caprine animals have been introduced.
|
|
II.2.3.
|
had no contact with animals of a lower health status since birth or for a period of at least 30 days prior to the date of their dispatch to the Union.’;
|
|
(ii)
|
point II.2.11.6 is replaced by the following:
‘either [II.2.11.6.
|
in which infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis) has not been reported during a period of at least 42 days prior to the date of dispatch of the animals to the Union](1)(8)
|
or [II.2.11.6.
|
subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis) in accordance with the procedures set out in points (1) and (2) of Part 1 of Annex II to Commission Delegated Regulation (EU) 2020/688 during a period of at least 12 months prior to the date of dispatch of the animals to the Union and during this period:
(i)
|
only caprine animals from establishments applying such surveillance have been introduced into the establishment;
|
(ii)
|
in the case where infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis) has been reported in caprine animals kept on the establishment, measures were taken in accordance with point (3) of Part 1 of Annex II to Delegated Regulation (EU) 2020/688].(1)(9)’;
|
|
|
(iii)
|
points II.2.11.9 and II.2.11.10 are replaced by the following:
‘II.2.11.9.
|
in which anthrax has not been reported for a period of at least 15 days prior to the date of dispatch of the animals to the Union;
|
either [II.2.11.10.
|
in which surra (Trypanosoma evansi) has not been reported for a period of at least 2 years prior to the date of dispatch of the animals to the Union.] (1)
|
or [II.2.11.10.
|
in which surra (Trypanosoma evansi) has not been reported for a period of at least 30 days prior to the date of dispatch of the animals to the Union and where that disease was reported in the establishment of origin during the 2 years prior to the date of dispatch of the animals to the Union, the establishment remained under restrictions until the infected animals were removed from the establishment and the remaining animals on the establishment were subjected with negative results to a test for surra (Trypanosoma evansi) as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date the infected animals were removed from the establishment.] (1)
|
[II.2.11.11.
|
in which Burkholderia mallei (glanders) has not been reported for a period of at least 6 months prior to the date of dispatch of the animals to the Union.](9)’;
|
|
(iv)
|
the footnotes to Part II are replaced by the following:
‘(1)
|
Keep as appropriate.
|
(2)
|
Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(3)
|
Date of loading: it must not be a date prior to the date of authorisation of the zone for entry into the Union, or a date in a period when restriction measures have been adopted by the Union against the entry into the Union of these animals from this zone.
|
(4)
|
For zones with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(5)
|
For zones with entry BTV in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(6)
|
For zones with entry SF-BTV in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(7)
|
For zones with entry SF-EHD in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(8)
|
Only for ovine animals.
|
(9)
|
Only for caprine animals.
|
(10)
|
In accordance with Article 10 of Delegated Regulation (EU) 2020/692.
|
(11)
|
Zones with entry BRU for ovine and caprine animals in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’
|
|
|
(b)
|
in Chapter 12, model EQUI-X is corrected as follows:
(i)
|
points II.1.1 and II.1.2 are replaced by the following:
‘II.1.1.
|
is not intended for slaughter for human consumption and not intended for slaughter in the framework of the eradication of a disease communicable to equine animals, and
(1)
either
|
[is a registered equine animal, as defined in Article 2, point (12), of Commission Delegated Regulation (EU) 2020/692.]
|
(1)
or
|
[is a registered horse as defined in Article 2, point (12), of Delegated Regulation (EU) 2020/692]
|
(1)
or
|
[is an equine animal other than a registered equine animal or a registered horse.]
|
|
II.1.2.
|
has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on … (insert date dd/mm/yyyy)(2), this date being within the 24 hour period or, in the case of a registered horse, within the 48 hour period or on the last working day prior to the departure of the animal from the registered establishment.’;
|
|
(ii)
|
the notes to Part I are replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
|
Box reference I.27
|
:
|
“Identification system”: The animal must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in the identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system and the anatomic place used on the animal. If a passport accompanies the animal, its number must be stated and the name of the competent authority which validated it.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (2) to (8) are replaced by the following:
‘(2)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(3)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(4)
|
Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop
|
(5)
|
Zone of the country or territory authorised for entry into the Union as appearing respectively in columns 2 and 5 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(6)
|
Only authorised if the country of dispatch is assigned to Sanitary Group G.
|
(7)
|
Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the numbering of the subsequent statements is maintained.
|
(8)
|
Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness:
https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/referencia-union-europea-oie/diagnostico/default.aspx’;
|
|
(iv)
|
in the Declaration by the operator responsible for the entry into the Union of the consignment of equine animal not intended for slaughter, footnote (1) is replaced by the following:
‘(1)
|
Identification system: The animal must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animal.
If a passport accompanies the animal, its number must be stated and the name of the competent authority which validated it.
Age: Date of birth (dd/mm/yyyy).
Sex (M = male, F = female, C = castrated).’;
|
|
|
(c)
|
in Chapter 13, model EQUI-Y is corrected as follows:
(i)
|
point II.1.2 is replaced by the following:
‘II.1.2.
|
have not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on … (insert date dd/mm/yyyy)(2), this date being within the 24 hour period prior to departure:
(3)either
|
[from the registered establishment of origin in the country, territory or zone thereof of dispatch;]
|
(3)or
|
[from the establishment approved for conducting assembly operations of equine animals by the competent authority in the country or territory of dispatch in accordance with requirements at least as stringent as those laid down in Article 5 of Commission Delegated Regulation (EU) 2019/2035;]’;
|
|
|
(ii)
|
the Notes to Part I are replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
|
Box reference I.27
|
:
|
“Identification system”: The animals must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692 which permits to link the animals to the animal health/official certificate. Specify the identification system and the anatomic place used on the animals.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (2) to (4) are replaced by the following:
‘(2)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animals were loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(3)
|
Delete as appropriate.
|
(4)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.’;
|
|
(iv)
|
in the Notes to Part II, footnote (7) is replaced by the following:
‘(7)
|
Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness:
https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/referencia-union-europea-oie/diagnostico/default.aspx’;
|
|
(v)
|
in the Declaration by the operator responsible for the entry into the Union of the consignment of equine animals intended for slaughter, footnote (1) is replaced by the following:
‘(1)
|
Identification system: The animals must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692 which permits to link the animals to the animal health/official certificate. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animals.’;
|
|
|
(d)
|
in Chapter 14, model EQUI-TRANSIT-X is corrected as follows:
(i)
|
points II.1.1 and II.1.2 are replaced by the following:
‘II.1.1.
|
is not intended for slaughter for human consumption and not intended for slaughter in the framework of the eradication of a disease communicable to equine animals, and
(1)
either
|
[is a registered equine animal, as defined in Article 2, point (12), of Commission Delegated Regulation (EU) 2020/692.]
|
(1)
or
|
[is a registered horse as defined in Article 2, point (12), of Delegated Regulation (EU) 2020/692.]
|
(1)
or
|
[is an equine animal other than a registered equine animal or a registered horse.]
|
|
II.1.2.
|
has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on … (insert date dd/mm/yyyy)(2), this date being within the 24 hour period, or in the case of a registered horse within the 48 hour period or on the last working day, prior to departure from the registered establishment.’;
|
|
(ii)
|
the Notes to Part I are replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
|
Box reference I.27
|
:
|
“Identification system”: The animal must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in the identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system and the anatomic place used on the animal. If a passport accompanies the animal, its number must be stated and the name of the competent authority which validated it.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (2) to (8) are replaced by the following:
‘(2)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(3)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(4)
|
Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop
|
(5)
|
Zone of country or territory authorised for entry into the Union as appearing respectively in columns 2 and 5 of the table Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(6)
|
Only authorised if country of dispatch is assigned to Sanitary Group G.
|
(7)
|
Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the numbering of the subsequent statements is maintained.
|
(8)
|
Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness:
https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/referencia-union-europea-oie/diagnostico/default.aspx’;
|
|
(iv)
|
in the Declaration by the operator responsible for the transit through the Union of the consignment of equine animal not intended for slaughter, footnote (1) is replaced by the following:
‘(1)
|
Identification system: The animal must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in the identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animal.
If a passport accompanies the animal, its number must be stated and the name of the competent authority which validated it.
Age: Date of birth (dd/mm/yyyy).
Sex (M = male, F = female, C = castrated).’;
|
|
|
(e)
|
in Chapter 15, model EQUI-TRANSIT-Y is corrected as follows:
(i)
|
point II.1.2 is replaced by the following:
‘II.1.2.
|
have not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on … (insert date dd/mm/yyyy)(2), this date being within the 24 hour period prior to departure:
(3)either
|
[from the registered establishment of origin in the country, territory or zone thereof of dispatch;]
|
(3)or
|
[from the establishment approved for conducting assembly operations of equine animals by the competent authority in the country, territory or zone thereof of dispatch in accordance with requirements at least as stringent as those laid down in Article 5 of Commission Delegated Regulation (EU) 2019/2035;]’;
|
|
|
(ii)
|
the Notes to Part I are replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 to Annex IV to Commission Implementing Regulation (EU) 2021/404.
|
Box reference I.27
|
:
|
“Identification system”: The animals must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692 which permits to link the animals to the animal health/official certificate. Specify the identification system and the anatomic place used on the animals.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (2) to (4) are replaced by the following:
‘(2)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animals were loaded either prior to the date of authorisation for entry into the Union from the respective country or territory, or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(3)
|
Delete as appropriate.
|
(4)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.’;
|
|
(iv)
|
in the Notes to Part II, footnote (7) is replaced by the following:
‘(7)
|
Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness:
https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/referencia-union-europea-oie/diagnostico/default.aspx’;
|
|
(v)
|
in the Declaration by the operator responsible for the transit through the Union of the consignment of equine animals intended for slaughter, footnote (1) is replaced by the following:
‘(1)
|
Identification system: The animals must be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, which permits to link the animals to the animal health/official certificate. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animal.’;
|
|
|
(f)
|
in Chapter 16, model EQUI-RE-ENTRY-30 is corrected as follows:
(i)
|
points II.2.4 to II.2.7 are replaced by the following:
‘II.2.4.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported during the 36 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for infection with Burkholderia mallei (glanders) recognised by the Union(1) has been carried out during the 36 month period prior to the date of departure, and
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the 36 month period prior to the date of departure of the animal.]]
|
(3)or
|
[infection with Burkholderia mallei (glanders) has been reported in the establishment during the 36 month period prior to the date of departure of the animal and following the last outbreak, the establishment has remained under movement restrictions:
(3)either
|
[until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders)(4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least six months after the date the infected animals have been killed and destroyed.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was killed and destroyed.]]]
|
|
|
|
II.2.5.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[surra has not been reported during the 24 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for surra recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either
|
[surra has not been reported in the establishment during the 24 months period prior to the date of departure of the animal.]]
|
(3)or
|
[surra has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak the establishment has remained under movement restrictions:
(3)either
|
[until the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4) carried out, with negative results, on samples taken at least six months after the date the last infected animal has been removed from the establishment.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last animal of listed species on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.6.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[dourine has not been reported during the 24 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for dourine recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either
|
[dourine has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.]]
|
(3)or
|
[dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment has remained under movement restrictions:
(3)either
|
[until the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5(4) on samples taken at least six months after the date the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.7.
|
The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the 60 day period prior to the date of its departure, and
(3)either
|
[it comes from an establishment situated in a country or territory in which Venezuelan equine encephalomyelitis has not been reported during the 24 month period prior to the date of its departure.]
|
(3)or
|
[it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the six month period prior to the date of its departure and which is situated in a country, territory or zone thereof in which a surveillance and eradication programme for Venezuelan equine encephalomyelitis recognised by the Union(1) has been carried out during the 24 month period prior to the date of its departure.]’;
|
|
|
(ii)
|
in the Notes to Part I, Box reference I.8 is replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (1) to (2) are replaced by the following:
‘(1)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(2)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.’;
|
|
|
(g)
|
in Chapter 17, model EQUI-RE-ENTRY-90-COMP is corrected as follows:
(i)
|
points II.2.4 to II.2.7 are replaced by the following:
‘II.2.4.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported during the 36 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for infection with Burkholderia mallei (glanders) recognised by the Union(1) has been carried out during the 36 month period prior to the date of departure, and
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the 36 month period prior to the date of departure of the animal.]]
|
(3)or
|
[infection with Burkholderia mallei (glanders) has been reported in the establishment during the 36 month period prior to the date of departure of the animal and following the last outbreak, the establishment has remained under movement restrictions:
(3)either
|
[until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders)(4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least six months after the date the infected animals have been killed and destroyed.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was killed and destroyed.]]]
|
|
|
|
II.2.5.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[surra has not been reported during the 24 month period prior to the date of departure.]
|
(3)or
|
[a surveillance and eradication programme for surra recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either
|
[surra has not been reported in the establishment during the 24 months period prior to the date of departure of the animal.]]
|
(3)or
|
[surra has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak the establishment has remained under movement restrictions:
(3)either
|
[until the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4) carried out, with negative results, on samples taken at least six months after the date the last infected animal has been removed from the establishment.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last animal of listed species on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.6.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[dourine has not been reported during the 24 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for dourine recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either
|
[dourine has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.]]
|
(3)or
|
[dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment has remained under movement restrictions:
(3)either
|
[until the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5(4) on samples taken at least six months after the date the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.7.
|
The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the 60 day period prior to the date of its departure, and
(3)either
|
[it comes from an establishment situated in a country or territory in which Venezuelan equine encephalomyelitis has not been reported during the 24 month period prior to the date of its departure.]
|
(3)or
|
[it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the six month period prior to the date of its departure and which is situated in a country, territory or zone thereof in which a surveillance and eradication programme for Venezuelan equine encephalomyelitis recognised by the Union(1) has been carried out during the 24 month period prior to the date of its departure.]’;
|
|
|
(ii)
|
in the Notes to Part I, Box reference I.8 is replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (1) to (2) are replaced by the following:
‘(1)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(2)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.’;
|
|
|
(h)
|
in Chapter 18, model EQUI- RE-ENTRY-90-RACE is corrected as follows:
(i)
|
points II.2.4 to II.2.7 are replaced by the following:
‘II.2.4.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported during the 36 month period prior to the date of departure of the animal.]
|
(3)or
|
[a surveillance and eradication programme for infection with Burkholderia mallei (glanders) recognised by the Union(1) has been carried out during the 36 month period prior to the date of departure, and
(3)either
|
[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the 36 month period prior to the date of departure of the animal.]]
|
(3)or
|
[infection with Burkholderia mallei (glanders) has been reported in the establishment during the 36 month period prior to the date of departure of the animal and following the last outbreak, the establishment has remained under movement restrictions:
(3)either
|
[until the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders)(4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least six months after the date the infected animals have been killed and destroyed.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was killed and destroyed.]]]
|
|
|
|
II.2.5.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)either
|
[surra has not been reported during the 24 month period prior to the date of departure.]
|
(3)or
|
[a surveillance and eradication programme for surra recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)either
|
[surra has not been reported in the establishment during the 24 months period prior to the date of departure of the animal.]]
|
(3)or
|
[surra has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak the establishment has remained under movement restrictions:
(3)either
|
[until the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4(4) carried out, with negative results, on samples taken at least six months after the date the last infected animal has been removed from the establishment.]]]
|
(3)or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last animal of listed species on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.6.
|
The equine animal described in Part I comes from an establishment situated in a country, territory or zone thereof in which:
(3)
either
|
[dourine has not been reported during the 24 month period prior to the date of departure of the animal.]
|
(3)
or
|
[a surveillance and eradication programme for dourine recognised by the Union(1) has been carried out during the 24 month period prior to the date of departure of the animal, and
(3)
either
|
[dourine has not been reported in the establishment during the 24 month period prior to the date of departure of the animal.]]
|
(3)
or
|
[dourine has been reported in the establishment during the 24 month period prior to the date of departure of the animal, and following the last outbreak, the establishment has remained under movement restrictions:
(3)
either
|
[until the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5(4) on samples taken at least six months after the date the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated.]]]
|
(3)
or
|
[for a period of at least 30 days from the date of cleaning and disinfection of the establishment, after the last equine animal on the establishment was either killed and destroyed or slaughtered.]]]
|
|
|
|
II.2.7.
|
The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the 60 day period prior to the date of its departure, and
(3)
either
|
[it comes from an establishment situated in a country or territory in which Venezuelan equine encephalomyelitis has not been reported during the 24 month period prior to the date of its departure.]
|
(3)
or
|
[it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the six month period prior to the date of its departure and which is situated in a country, territory or zone thereof in which a surveillance and eradication programme for Venezuelan equine encephalomyelitis recognised by the Union(1) has been carried out during the 24 month period prior to the date of its departure.]’;
|
|
|
(ii)
|
in the Notes to Part I, Box reference I.8 is replaced by the following:
‘Box reference I.8
|
:
|
Provide the code of the country, territory or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.’;
|
|
(iii)
|
in the Notes to Part II, footnotes (1) and (2) are replaced by the following:
‘(1)
|
The certificate must be issued within the period of 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for entry into the Union from the respective country, territory or zone thereof referred to in point II.2.1., or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from this country, territory or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.
|
(2)
|
Code of the country, territory or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.’;
|
|
|
(i)
|
in Chapter 19, in model CONFINED-RUM, Section 2 is corrected as follows:
(i)
|
points II.1.2 and II.1.3 are replaced by the following:
‘II.1.2.
|
have remained continuously in the establishment of origin since birth or for a period of at least six months prior to the date of dispatch to the Union.
|
II.1.3.
|
have not been in contact with animals of a lower health status for a period of 30 days prior to the date of dispatch to the Union, or since birth if the animals are less than 30 days of age, and during their transport from the approved confined establishment of origin to the place of dispatch to the Union.’;
|
|
(ii)
|
point II.1.6 is replaced by the following:
‘II.1.6.
|
have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11. since they were dispatched from their establishment of origin until their dispatch to the Union and during that period they have not been in contact with animals of a lower health status.’;
|
|
(iii)
|
in the Notes to Part II, footnote (2) is replaced by the following:
‘(2)
|
Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.’;
|
|
|
(j)
|
in Chapter 20, in model CONFINED-SUI, Section 2 is corrected as follows:
(i)
|
points II.1.2 and II.1.3 are replaced by the following:
‘II.1.2.
|
have remained continuously in the establishment of origin since birth or for a period of at least six months prior to the date of dispatch to the Union.
|
II.1.3.
|
have not been in contact with animals of a lower health status for a period of 30 days prior to the date of dispatch to the Union, or since birth if the animals are less than 30 days of age, and during their transport from the approved confined establishment of origin to the place of dispatch to the Union.’;
|
|
(ii)
|
point II.1.6 is replaced by the following:
‘II.1.6.
|
have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11. since they were dispatched from their establishment of origin until their dispatch to the Union and during that period they have not been in contact with animals of a lower health status.’;
|
|
(iii)
|
point II.1.14 is replaced by the following:
‘
(1)(4)
[
either (1)
[II.1.14.
|
come from a zone in which at the date of issue of this certificate African swine fever has not been reported during the preceding 12 month period.]]
|
or (1)
[II.1.14.
|
have undergone a virology and serology test for the detection of African swine fever and in accordance with the test prescribed for international trade in the OIE Terrestrial Manual, carried out on samples taken during the period of 30 days prior to the date of dispatch to the Union.]]’;
|
|
(iv)
|
in the Notes to Part II, footnote (2) is replace by the following:
‘(2)
|
Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.’;
|
|
|
(k)
|
in Chapter 21, in model CONFINED-TRE, Section 2 is corrected as follows:
(i)
|
points II.1.2 and II.1.3 are replaced by the following:
‘II.1.2.
|
have remained continuously in the establishment of origin since birth or for a period of at least six months prior to the date of dispatch to the Union.
|
II.1.3.
|
have not been in contact with animals of a lower health status for a period of 30 days prior to the date of dispatch to the Union, or since birth if the animals are less than 30 days of age, and during their transport from the approved confined establishment of origin to the place of dispatch to the Union.’;
|
|
(ii)
|
point II.1.6 is replaced by the following:
‘II.1.6.
|
have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11. since they were dispatched from their establishment of origin until their dispatch to the Union and during that period they have not been in contact with animals of a lower health status.’;
|
|
(iii)
|
in the Notes to Part II, footnote (2) is replace by the following:
‘(2)
|
Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.’;
|
|
|
(l)
|
in Chapter 22, model CONFINED-HIPPO is corrected as follows:
(i)
|
points II.1.2 and II.1.3 are replaced by the following:
‘II.1.2.
|
have remained continuously in the establishment of origin since birth or for a period of at least six months prior to the date of dispatch to the Union.
|
II.1.3.
|
have not been in contact with animals of a lower health status for a period of 30 days prior to the date of dispatch to the Union, or since birth if the animals are less than 30 days of age, and during their transport from the approved confined establishment of origin to the place of dispatch to the Union.’;
|
|
(ii)
|
point II.1.6 is replaced by the following:
‘II.1.6.
|
have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11. since they were dispatched from their establishment of origin until their dispatch to the Union and during that period they have not been in contact with animals of a lower health status.’;
|
|
(iii)
|
points II.1.11.3 to II.1.11.5 are replaced by the following:
‘II.1.11.3.
|
in which at the date of issue of this animal health certificate the following diseases have not been reported during the preceding six month period:
—
|
foot and mouth disease,
|
—
|
infection with rinderpest virus,
|
—
|
infection with Rift Valley fever virus,
|
—
|
infection with Brucella abortus, B. melitensis and B. suis,
|
—
|
infection with Mycobacterium tuberculosis complex (M. bovis, M.caprae, M.Tuberculosis),
|
|
II.1.11.4.
|
in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported during the period of 30 days prior to the date of dispatch to the Union.
|
II.1.11.5.
|
around which, in an area with a 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported during the period of 30 days prior to the date of dispatch to the Union:
—
|
foot and mouth disease,
|
—
|
infection with rinderpest virus,
|
—
|
infection with Brucella abortus, B. melitensis and B. suis,
|
—
|
infection with Mycobacterium tuberculosis complex (M. bovis, M.caprae, M.Tuberculosis).
|
|
II.1.11.6.
|
around which, in an area with a 150 km radius, including where appropriate the territory of a neighbouring country, infection with Rift Valley fever virus has not been reported during the period of 30 days prior to the date of dispatch to the Union.’;
|
|
(iv)
|
in the Notes to Part II, footnote (2) is replace by the following:
‘(2)
|
Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.’;
|
|
|
(m)
|
in Chapter 34a, model RACING PIGEONS-IMMEDIATE RELEASE is corrected as follows:
(i)
|
point I.18 is replaced by the following:
‘I.18
|
Transport conditions
|
|
|
|
|
(ii)
|
point II.1.2 is replaced by the following:
‘II.1.2.
|
come from the establishment indicated in Box I.11 registered by the competent authority of the third country or territory of origin or zone thereof, and:
(a)
|
within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza or infection with Newcastle disease virus for a period of at least 30 days prior to the date of loading for dispatch to the Union;
|
(b)
|
in which the vaccination against infection with Newcastle disease virus is carried out.’;
|
|
|
(iii)
|
point II.1.6 is replaced by the following:
‘II.1.6.
|
are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(2) in a means of transport which:
(a)
|
is constructed in such a way that:
(i)
|
animals cannot escape or fall out;
|
(ii)
|
visual inspection of the space where animals are kept is possible;
|
(iii)
|
the escape of animal excrements, litter, feed or feathers is prevented or minimised;
|
|
(b)
|
contains only racing pigeons;
|
(c)
|
was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory of origin, or zone thereof.’;
|
|
|
|
(n)
|
in Chapter 39, model BOV-SEM-A-ENTRY is corrected as follows:
(i)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Type”: Indicate semen.
“Species”: Select amongst “Bos taurus”, “Bison bison” or “Bubalus bubalis” as appropriate.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed.
“Date of collection/production” : Indicate the date on which semen of the consignment was collected.
“Approval or registration number of plant/establishment/centre” : Indicate the unique approval number of the semen collection centre where the semen was collected.
“Quantity”: Indicate the number of straws or other packages with the same mark.
“Test”: Indicate for BTV-test: II.4.8.5. and/or II.4.8.6., and/or for EHD-test: II.4.9.3.1. and/or II.4.9.3.2., if relevant.’;
|
|
(ii)
|
in the Notes to Part II, footnote (2) is replaced by the following:
‘(2)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(o)
|
in Chapter 42, model ‘BOV-OOCYTES-EMB-A-ENTRY is corrected and amended as follows:
(i)
|
in Part II, point II.2. is replaced by the following:
‘
(1)
[II.2.
|
The in vivo derived embryos described in Part I have been collected, processed and stored, and dispatched by the embryo collection team(3) which:
II.2.1.
|
is approved and listed by the competent authority of the third country or territory;
|
II.2.2.
|
complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]
|
|
(1)
[II.2.
|
The oocytes(1)/in vitro produced embryos(1) described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team(3) which:
II.2.1.
|
is approved and listed by the competent authority of the third country or territory;
|
II.2.2.
|
complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]’;
|
|
|
(ii)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Species”: Select amongst “Bos taurus”, “Bison bison” or “Bubalus bubalis” as appropriate.
“Type” : Specify if oocytes, in vivo derived embryos, in vitro produced embryos or micromanipulated embryos.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed.
“Date of collection/production” : Indicate the date on which oocytes or embryos of the consignment were collected or produced.
“ Approval or registration number of plant/establishment/centre” : Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos were collected or produced.
“Quantity”: Indicate the number of straws or other packages with the same mark.
“Test”: Indicate for BTV-test: II.4.7.5. and/or II.4.7.6., and/or for EHD-test: II.4.8.3.1. and/or II.4.8.3.2., if relevant.’;
|
|
(iii)
|
in the Notes to Part II, footnote (2) is replaced by the following:
‘(2)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(p)
|
in Chapter 47, model BOV-GP-STORAGE-ENTRY is corrected as follows:
(i)
|
the introductory Notes are replaced by the following:
‘Notes
This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of bovine animals, including when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.’;
|
(ii)
|
in the Notes to Part II, footnote (3) is replaced by the following:
‘(3)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(q)
|
in Chapter 48, model OV/CAP-SEM-A-ENTRY is corrected and amended as follows:
(i)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Type”: Indicate semen.
“Species”: Select amongst “Ovis aries” or “Capra hircus” as appropriate.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed.
“Date of collection/production”: Indicate the date on which semen of the consignment was collected.
“Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen was collected.
“Quantity”: Indicate the number of straws or other packages with the same mark.
“Test”: Indicate for BTV-test: II.4.8.5. and/or II.4.8.6., and/or for EHD-test: II.4.9.3.1. and/or II.4.9.3.2., if relevant.’;
|
|
(ii)
|
in the Notes to Part II, footnote (2) is replaced by the following:
‘(2)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(r)
|
in Chapter 50, model OV/CAP-OOCYTES-EMB-A-ENTRY is corrected an amended as follows:
(i)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Type” : specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos.
“Species”: select amongst “Ovis aries” or “Capra hircus” as appropriate.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed.
“Date of collection/production” : Indicate the date on which oocytes or embryos of the consignment were collected or produced.
“Approval or registration number of plant/establishment/centre” : Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos were collected or produced.
“Quantity”: Indicate the number of straws or other packages with the same mark.
“Test”: Indicate for BTV-test: II.4.7.5. and/or II.4.7.6., and/or for EHD-test: II.4.8.3.1. and/or II.4.8.3.2., if relevant.’;
|
|
(ii)
|
in the Notes to Part II, footnote (2) is replaced by the following:
‘(2)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(s)
|
in Chapter 53, model OV/CAP-GP-STORAGE-ENTRY is corrected as follows:
(i)
|
the introductory Notes are replaced by the following:
‘Notes
This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the semen, oocytes and embryos.
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.’;
|
(ii)
|
in the Notes to Part II, footnote (3) is replaced by the following:
‘(3)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(t)
|
in Chapter 54, model POR-SEM-A-ENTRY is corrected as follows:
(i)
|
point II.4.8.3 is replaced by the following:
‘(1)[II.4.8.3.
|
as regards classical swine fever, an antibody ELISA or serum neutralisation test, in the case of animals coming from a third country or territory or zone thereof where classical swine fever has been reported or vaccination against this disease has been practiced for the period of the preceding 12 months;]’;
|
|
(ii)
|
point II.4.9.3 is replaced by the following:
‘(1)[II.4.9.3.
|
as regards classical swine fever, an antibody ELISA or serum neutralisation test, in the case of animals coming from a third country or territory or zone thereof where classical swine fever has not been reported and vaccination against this disease has not been practiced for the period of the preceding 12 months;]’;
|
|
(iii)
|
in the Notes to Part II, footnotes (2) and (3) are replaced by the following:
‘(2)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.
|
(3)
|
Only for a third country, territory or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.’;
|
|
|
(u)
|
in Chapter 59, model EQUI-SEM-A-ENTRY is corrected and amended as follows:
(i)
|
in Part II, point II.4.4.2 is replaced by the following:
‘II.4.4.2.
|
were kept on establishments where Venezuelan equine encephalomyelitis, dourine, surra (Trypanosoma evansi), equine infections anaemia, contagious equine metritis (Taylorella equigenitalis), infection with rabies virus and anthrax have not been reported;’;
|
|
(ii)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Type”: Indicate semen.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed.
“Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy.
“Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen was collected.
“Quantity”: Indicate the number of straws or other packages with the same mark.
“Test”: Indicate ‘Yes, see points II.4.9. and II.4.10’.’;
|
|
|
(v)
|
in Chapter 63, model EQUI-OOCYTES-EMB-A-ENTRY is corrected as follows:
(i)
|
point II.4.4.2 is replaced by the following:
‘II.4.4.2.
|
were kept on establishments where Venezuelan equine encephalomyelitis, dourine, surra (Trypanosoma evansi), equine infections anaemia, contagious equine metritis (Taylorella equigenitalis), infection with rabies virus and anthrax have not been reported;’;
|
|
(ii)
|
in the Notes to Part I, Box reference I.27 is replaced by the following:
‘Box reference I.27
|
:
|
“Type” : Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos.
“Identification number”: Indicate the identification number of each donor animal.
“Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed.
“Date of collection/production” : Indicate the date on which oocytes or embryos of the consignment were collected or produced.
“Approval or registration number of plant/establishment/centre” : Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos were collected or produced.
“Quantity”: Indicate the number of straws or other packages with the same mark.’.
|
|
|
|